Improving Validation Practices in “Omics” Research
- 2 December 2011
- journal article
- perspective
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 334 (6060), 1230-1232
- https://doi.org/10.1126/science.1211811
Abstract
“Omics” research poses acute challenges regarding how to enhance validation practices and eventually the utility of this rich information. Several strategies may be useful, including routine replication, public data and protocol availability, funding incentives, reproducibility rewards or penalties, and targeted repeatability checks.Keywords
This publication has 20 references indexed in Scilit:
- Temporal Trends in Results Availability from Genome-Wide Association StudiesPLoS Genetics, 2011
- Public Availability of Published Research Data in High-Impact JournalsPLOS ONE, 2011
- Biomarker studies: a call for a comprehensive biomarker study registryNature Reviews Clinical Oncology, 2011
- An empirical assessment of validation practices for molecular classifiersBriefings in Bioinformatics, 2011
- Proteomics Research to Discover Markers: What Can We Learn from Netflix®?Clinical Chemistry, 2010
- A HUPO test sample study reveals common problems in mass spectrometry–based proteomicsNature Methods, 2009
- The Evaluation of Genomic Applications in Practice and Prevention (EGAPP) initiative: methods of the EGAPP Working GroupGenetics in Medicine, 2009
- Replicating genotype–phenotype associationsNature, 2007
- Critical Review of Published Microarray Studies for Cancer Outcome and Guidelines on Statistical Analysis and ReportingJNCI Journal of the National Cancer Institute, 2007
- Why Most Published Research Findings Are FalsePLoS Medicine, 2005